OraVerse (phentolamine mesylate) Injection
Date of Approval: May 9, 2008
Company: Novalar Pharmaceuticals, Inc.
Treatment for: Reversal of Anesthesia
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.
No comments:
Post a Comment